- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Tumor in Canada
Total 1255 results
-
NCIC Clinical Trials GroupCompletedPain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant ConditionCanada
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, Canada, France, Taiwan, Belgium, Spain, Singapore, Italy, Australia, Hong Kong, Germany, Japan
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
VicalCompletedMetastatic MelanomaUnited States, Belgium, Brazil, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Switzerland, Turkey
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); Roswell Park Cancer Institute; American Lebanese...RecruitingGlioblastoma Multiforme | Ependymoma | Medulloblastoma | Anaplastic Astrocytoma | Anaplastic Ependymoma | Anaplastic Oligodendroglioma | Diffuse Intrinsic Pontine Glioma | High-grade Astrocytoma NOSUnited States, Canada
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Mural Oncology, IncCompletedAdvanced Solid TumorsKorea, Republic of, United States, Canada, Netherlands, Spain, Taiwan
-
Eli Lilly and CompanyCompletedBreast Cancer | Early-Stage Breast Carcinoma | Hormone Receptor Positive TumorUnited States, Canada, Korea, Republic of, Italy, Austria, Belgium, Germany, Netherlands, Spain, Taiwan
-
AmgenMerck Sharp & Dohme LLCCompletedMelanomaUnited States, Canada, Spain, France, Australia, Greece, Italy, United Kingdom, Germany, Netherlands, Poland
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Novartis PharmaceuticalsCompletedNeuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung OriginUnited States, Colombia, Italy, Taiwan, United Kingdom, Belgium, Czechia, Germany, Japan, Saudi Arabia, Canada, Netherlands, Spain, Korea, Republic of, Lebanon, Austria, China, Greece, South Africa, Thailand, Hungary, Turkey, Poland, ... and more
-
Universitätsmedizin MannheimUniversity of California, Los Angeles; Carl Zeiss Meditec AGRecruitingGlioblastomaKorea, Republic of, Germany, Canada, Spain, United States, Brazil, China, United Kingdom
-
Bristol-Myers SquibbNo longer availableStage III (Unresectable) or Stage IV Advanced MelanomaUnited States, Canada, Argentina, Colombia, Peru, Brazil
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Merck Sharp & Dohme LLCRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaAustralia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
-
OSI PharmaceuticalsTerminatedEpendymomaUnited States, Canada, United Kingdom
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer... and other conditionsUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Stage 4S Neuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedPrecancerous Condition | Adrenocortical Carcinoma | Localized Resectable NeuroblastomaUnited States, Canada, Australia
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, Poland, United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Netherlands, Norway, Romania, Spain, Switzerland, United Kingdom, Sweden
-
Southwest Oncology GroupNational Cancer Institute (NCI); Agency for Healthcare Research and Quality...CompletedUnspecified Adult Solid Tumor, Protocol Specific | Constipation, Impaction, and Bowel ObstructionUnited States, Canada, Colombia, Peru, Mexico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Refractory Childhood Hodgkin Lymphoma | Recurrent Childhood Hodgkin LymphomaUnited States, Canada
-
GlaxoSmithKlineTerminatedMelanomaUnited States, Australia, Spain, Taiwan, Bulgaria, Estonia, Germany, Belgium, France, Sweden, Israel, Poland, Italy, Czechia, Switzerland, Korea, Republic of, Ireland, Canada, Argentina, Netherlands, Russian Federation, Ukraine, Aus... and more
-
AstraZenecaCompletedLymphoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Malignant Solid TumorsUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid LeukemiaCanada, United States
-
Novartis PharmaceuticalsCompleted3rd Line GISTFrance, United Kingdom, Belgium, Canada, Spain, Netherlands, Japan, United States
-
University of CincinnatiNational Center for Research Resources (NCRR); Office of Rare Diseases (ORD); FDA Office of Orphan Products DevelopmentCompletedLymphangioleiomyomatosisUnited States, Canada, Japan
-
Syros PharmaceuticalsTerminatedBreast Cancer | Ovarian Cancer | Advanced Solid TumorsUnited States, Canada, France
-
Merck Sharp & Dohme LLCActive, not recruitingRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States, China, Poland, Israel, Canada, Chile, Czechia, Estonia, France, Greece, Italy, Korea, Republic of, Norway, Spain, Sweden, Thailand, Turkey
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
-
AmgenRecruitingAdvanced MTAP-null Solid TumorsUnited States, Canada, Taiwan, Switzerland, United Kingdom, Korea, Republic of, Germany, Austria, France, Belgium, Australia, Hong Kong, Japan
-
Novartis PharmaceuticalsTerminatedSolid Tumors and LymphomasUnited States, Australia, Netherlands, Canada, Germany, Switzerland, Japan, Spain
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 Neuroblastoma | Stage 1 Neuroblastoma | Stage 2 NeuroblastomaUnited States, Canada, Australia, New Zealand
-
AbbVieRoche-GenentechCompletedNon-Hodgkin's Lymphoma | Neuroblastoma | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | MalignanciesUnited States, Australia, Canada, France, Germany, Netherlands, Switzerland, United Kingdom
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Italy, Poland, United States, Thailand, United Kingdom, Belgium, Turkey, Czechia
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 NeuroblastomaUnited States, Puerto Rico, Canada, Australia, New Zealand, Netherlands, Saudi Arabia, Switzerland
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingCancer Survivor | Retinoblastoma | Unilateral Retinoblastoma | Intraocular Retinoblastoma | Biological SiblingUnited States, Canada
-
Novartis PharmaceuticalsCompletedMelanoma and Brain MetastasesCanada, United States, Australia, France, Germany, Italy, Spain
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Hoffmann-La RocheTerminatedAdvanced BRAFV600 Wild-type MelanomaUnited States, Korea, Republic of, Australia, Belgium, France, Russian Federation, Italy, Netherlands, Spain, United Kingdom, Brazil, Poland, Germany, Greece, Hungary
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology... and other collaboratorsActive, not recruitingMelanoma (Skin)United States, Canada, Australia, South Africa
-
Volastra Therapeutics, Inc.AmgenCompletedAdvanced Solid TumorsUnited States, Canada, Italy, Australia, Japan, Belgium, Spain
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaCanada, United States, Australia, Belgium, Brazil, Chile, France, Germany, Israel, Italy, Japan, Poland, South Africa, Spain, Switzerland, United Kingdom
-
Hoffmann-La RocheCompletedMelanomaUnited States, Israel, Italy, Spain, Belgium, United Kingdom, Austria, Czechia, France, Netherlands, New Zealand, Russian Federation, Australia, Canada, Croatia, Portugal, Germany, Ukraine, Switzerland, Argentina, Brazil, Ireland, N... and more